Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Ordinary Shares, nominal value 0.003, per ordinary share · CUSIP: 589492107

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rock Springs Capital Management LP

    Shares: 33,421,235.00 · Class: 4.2%

  • Rock Springs Capital LLC

    Shares: 33,421,235.00 · Class: 4.2%

  • Rock Springs Capital Master Fund LP

    Shares: 25,808,055.00 · Class: 3.2%

  • Mark Bussard

    Shares: 33,421,235.00 · Class: 4.2%

  • Kris Jenner

    Shares: 33,421,235.00 · Class: 4.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-002074
Form type
SCHEDULE 13G/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub